Aker Christopher Ray - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Aker Christopher Ray's relationship to Regulus Therapeutics Inc. (RGLS) is Officer (Sr. VP & General Counsel), and currently has 83,125 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RGLS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Aker Christopher Ray - Insider Non-Derivative Transactions of RGLS Common Stock

Aker Christopher Ray - Insider Non-Derivative Transactions at RGLS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Disposition -- (Common Stock)	83125	0	0
Jun 26, 2025	U -- (Common Stock)	60796	0	83125
Jan 15, 2025	Sell -- (Common Stock)	5088	1.26	49546
Jan 14, 2025	Sell -- (Common Stock)	38547	1.26	54634
Jan 10, 2025	Acquisition -- (Common Stock)	66625	1.36	75681
Jan 10, 2025	Acquisition -- (Common Stock)	17500	1.3	93181
Jan 19, 2024	Sell -- (Common Stock)	5468	1.19	10056
Jan 13, 2024	Acquisition -- (Common Stock)	11250	0	15524